小鼠抗ELL單克隆抗體

Background:

Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Elongation factor component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968, PubMed:23932780). Specifically required for stimulating the elongation step of RNA polymerase II- and III-dependent snRNA gene transcription (PubMed:23932780). ELL also plays an early role before its assembly into in the SEC complex by stabilizing RNA polymerase II recruitment/initiation and entry into the pause site. Required to stabilize the pre-initiation complex and early elongation.

Applications:

WB, IHC

Name of antibody:

ELL

Immunogen:

Fusion protein of human ELL

Full name:

elongation factor for RNA polymerase II

Synonyms:

MEN; ELL1; PPP1R68; C19orf17

SwissProt:

P55199

IHC positive control:

Human breast tissue and Human colon tissue

IHC Recommend dilution:

200-500

WB Predicted band size:

68 KD

WB Positive control:

Jurkat, Hela cell lysates

WB Recommended dilution:

500-2000